Category : Search result: Hyderabad pharma


Odisha Approves Pharma & Medtech Policy 2025

Odisha's new Pharma & Medtech Policy 2025 aims to make the state a strategic hub for healthcare manufacturing. The policy includes plans for dedicated industrial parks and a roadmap aligned with India's 2047 vision. Read more.

Hyderabad: The Landlocked City of Pearls

Discover how Hyderabad, far from the coast, earned its title as India's 'City of Pearls' through royal patronage, skilled artisans from Basra, and generations of craftsmanship in Chandanpet.

Granules India's US facility passes FDA GMP inspection

Granules India's US subsidiary, Granules Consumer Health LLC, successfully cleared a USFDA GMP inspection with zero observations. This marks a significant achievement for the Hyderabad-based pharma major's OTC product operations in America.

Hyderabad RGIA faces chaos after threat, flight delays

Rajiv Gandhi International Airport in Hyderabad saw major chaos on Wednesday due to operational issues causing flight delays, a day after a security threat email. Passengers faced long check-in queues.

Sun Pharma's Ilumya for Psoriasis Launched in India

Sun Pharma introduces its global biologic Ilumya for moderate-to-severe plaque psoriasis in India. Backed by Phase-3 data, it offers long-lasting clearance with a strong safety profile. Learn more about this targeted therapy.

Hyderabad Headlines: Key Updates You Need

Get the latest Hyderabad news covering civic updates, traffic alerts, weather conditions, and key political developments. Stay informed with all major city headlines.

Hyderabad's Maqta Art District Losing Identity

Hyderabad's Maqta Art District, once India's third major art hub with 40 murals, now struggles with fading artworks and encroachments. Discover what happened to this open-air gallery.

India's Bulk Drug Makers Ramp Up CDMO Investments

Indian API manufacturers are shifting to high-value contract development, targeting $22-25 billion market by 2035 as global pharma diversifies from China. Read about the growth trajectory.

Sudeep Pharma IPO Lists on BSE, NSE Today

Sudeep Pharma makes its stock market debut today. With a GMP of ₹121, the IPO is set for 20% listing gains after a blockbuster 93.72 times subscription. Get all the live details.

Indian Companies Set for Semaglutide Device Windfall

Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.

Page 1 of 4